Kalaris Therapeutics, Inc. (KLRS) AI Stock Price Forecast & Investment Analysis
Latest Analysis Date: August 22, 2025
Kalaris Therapeutics, Inc. (KLRS) - Comprehensive Stock Analysis & Investment Research
Company Overview & Business Profile
Kalaris Therapeutics, Inc. (Stock Symbol: KLRS)
is a leading company in the Life Sciences sector
, specifically operating within the Biological Products, (No Diagnostic Substances) industry.
.
The company has established itself as
an emerging investment opportunity with substantial growth potential.
Financial Performance & Key Metrics Analysis
Market Capitalization: $47 million - Classified as a
small-cap investment offering high growth potential.
Advanced AI Stock Prediction & Price Target Analysis
🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Kalaris Therapeutics, Inc. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.
Market Position & Competitive Advantage Analysis
Kalaris Therapeutics, Inc. strategically competes in the highly dynamic
Biological Products, (No Diagnostic Substances) marketplace,
representing an emerging small-cap investment with substantial growth potential and market disruption capabilities
.
.
Kalaris Therapeutics, Inc. Stock Price Chart and Technical Analysis
Loading chart data...
Loading Kalaris Therapeutics, Inc. interactive price chart and technical analysis...
Deep dive into Kalaris Therapeutics, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.
Understanding Valuation Metrics
What these metrics mean: Valuation metrics help determine if Kalaris Therapeutics, Inc. stock is fairly priced compared to its earnings, assets, and market position.
How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.
For Kalaris Therapeutics, Inc.:
P/B Ratio0.88x
Market Cap$47M
EPS$-4.96
Book Value/Share$2.84
Understanding Profitability Metrics
What these metrics mean: These ratios measure how efficiently Kalaris Therapeutics, Inc. converts revenue into profit and generates returns for shareholders.
How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.
For Kalaris Therapeutics, Inc.:
Understanding Financial Health Metrics
What these metrics mean: These ratios assess Kalaris Therapeutics, Inc.'s ability to meet short-term obligations and manage debt levels effectively.
How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.
For Kalaris Therapeutics, Inc.:
Understanding Cash Flow Metrics
What these metrics mean: Cash flow metrics reveal Kalaris Therapeutics, Inc.'s ability to generate cash from operations and fund growth initiatives.
How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.
For Kalaris Therapeutics, Inc.:
Understanding Operational Efficiency Metrics
What these metrics mean: These ratios measure how effectively Kalaris Therapeutics, Inc. uses its assets and manages working capital.
How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.
For Kalaris Therapeutics, Inc.:
Understanding Financial Statement Data
What these metrics mean: Key figures from Kalaris Therapeutics, Inc.'s income statement and balance sheet showing absolute financial performance.
How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.
For Kalaris Therapeutics, Inc.:
Income Statement ($ Millions)
Balance Sheet Highlights ($ Millions)
Dividend & Shareholder Information
Shares Outstanding19M
Kalaris Therapeutics, Inc. (KLRS) Fundamental Analysis & Insider Trading Data
(Quarterly Financial Reports)
Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Kalaris Therapeutics, Inc. stock analysis.
Loading fundamental data...
Loading Kalaris Therapeutics, Inc. comprehensive fundamental analysis and insider trading data...
Latest Kalaris Therapeutics, Inc. Stock News & Market Analysis
Breaking news, analyst reports, and market updates affecting Kalaris Therapeutics, Inc. (KLRS) stock price and investment outlook.
The combined company will operate under the name Kalaris Therapeutics, Inc. and its shares are expected to begin trading on The Nasdaq Global Market on March 19, 2025 under the ticker symbol "KLRS." ...
Continuing to enroll nAMD patients in a Phase 1 trial of TH103, a novel, differentiated anti-VEGF agent engineered to potentially provide longer-lasting and increased anti-VEGF activity to treat ...
PALO ALTO, Calif., May 23, 2025 (GLOBE NEWSWIRE) -- Kalaris Therapeutics, Inc. (Nasdaq: KLRS) (“Kalaris”), a clinical-stage biopharmaceutical company dedicated to the development and ...
Get an in-depth profile of Kalaris Therapeutics Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information. As of ...
Kalaris Therapeutics, Inc. Competitors & Peer Analysis - Life Sciences Sector
Comparative analysis of Kalaris Therapeutics, Inc. against industry peers and competitors in the Life Sciences sector, featuring AI-powered forecasts and key financial metrics.
Frequently Asked Questions - Kalaris Therapeutics, Inc. Stock Forecast
How accurate are Kalaris Therapeutics, Inc. stock predictions?
Our AI model demonstrates 56% historical accuracy for KLRS predictions, based on advanced machine learning algorithms trained on over 10 years of market data.
What factors influence Kalaris Therapeutics, Inc. stock price forecasts?
Is Kalaris Therapeutics, Inc. a good investment in 2025?
Based on our AI analysis, Kalaris Therapeutics, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.
How often are Kalaris Therapeutics, Inc. forecasts updated?
Kalaris Therapeutics, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.
Want More Advanced Kalaris Therapeutics, Inc. Analysis?
Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Kalaris Therapeutics, Inc. stock.
